Customer News

Ambrx, Inc. chooses R&D Time software service

Ambrx located in La Jolla, California, has subscribed to R&D Time software service to collect, track and report project effort. Special emphasys will be put on tracking effort by collaborator. Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics.

Neurobiological Technologies, Inc. fast tracks the use of R&D Logic Budgeting Software

NTI located in Emeryville, California, has chosen R&D Logic budgeting software to create the next corporate plan. Neurobiological Technologies, Inc. is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates.

Tercica, Inc. selects R&D Logic Software

Tercica, Inc. located in Brisbane, California, has chosen R&D Logic software for corporate planning, tracking and financial reporting. Tercica is a biopharmaceutical company working to develop and commercialize therapeutics for growth and other endocrine disorders.

Savient Pharmaceuticals selects R&D Logic Software

Savient Pharmaceuticals located in East Brunswick, New Jersey, has selected R&D Logic software for corporate planning, tracking and financial reporting. Savient Pharmaceuticals is a specialty biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Catalyst Biosciences selects R&D Logic Software

Catalyst Biosciences located in South San Francisco, California, has opted to use R&D Logic software to collect time effort, and to track and report project resources. Catalyst Biosciences is a leading biotechnology company focused on developing proteases as a therapeutic platform for inflammation, cardiovascular, and angiogenesis-based disorders.

Via Pharmaceuticals, Inc. selects R&D Logic Software

Via Pharmaceuticals, Inc. located in San Francisco, California, has selected R&D Logic enterprise software for financial planning and analysis, consolidated reporting as well as for project effort collection and project portfolio specific planning and monitoring. VIA is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease.

Kalypsys, Inc. selects R&D Logic Software

Kalypsys, Inc. located in San Diego, California, has chosen R&D Logic software for tracking and planning project resources and time effort. Kalypsys is a clinical stage pharmaceutical company that is advancing the way drugs are discovered and developing breakthrough therapies for some of the world's most widespread diseases including cardiovascular/metabolic diseases, pain/inflammation and oncology.

FivePríme Therapeutics, Inc. selects R&D Logic Software

Five Príme Therapeutics, Inc. located in San Francisco, California, has selected R&D Logic software for planning, tracking and time collection. FivePríme Therapeutics, Inc. is a pre-clinical stage biotech company discovering and developing innovative protein and antibody therapeutics. FivePríme is developing treatments for cancer and diabetes and multiple leads in metabolic and immunologic diseases, oncology and regenerative medicine.

Macroflux Corporation selects R&D Logic Software

Macroflux Corporation located in Mountain View, California, has opted to use the R&D Logic complete enterprise solution for planning, tracking and time collection. Macroflux is a spin-out of ALZA Corporation (a subsidiary of Johnson & Johnson). The Macroflux system is based on a small patch and applicator that is intended to provide a needle-free solution for transdermal delivery of therapeutic proteins, peptides and vaccines. It is designed to combine painless and convenient drug administration with rapid delivery and high bioavailability.

SGX Pharmaceuticals selects R&D Logic Software for Planning and Tracking

SGX Pharmaceuticals Inc. located in San Diego, California, has decided to use R&D Logic enterprise solution to support FP&A company-wide processes. SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.

Alnylam Pharmaceuticals selects R&D Logic Software

Alnylam Pharmaceuticals Inc. located in Cambridge, Massachusetts, has selected R&D Manage, R&D Time and R&D P&L to support corporate strategic and operational planning as well as monthly tracking and analysis. Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference, or RNAi.

Momenta Pharmaceuticals selects R&D Logic Enterprise Solution

Momenta Pharmaceuticals Inc. located in Cambridge, Massachusetts, has selected R&D Logic suite of software to support planning, tracking, time collection and corporate analysis and reporting. Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars (polysaccharides) for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes.

InterMune chooses R&D Resource software

InterMune Inc. located in Brisbane, California, has opted to use R&D Logic software to support Project Time collection as well Time off collection and tracking, our latest addition to the enterprise solution. In addition, InterMune will be using software capabilities to track and analyze resource utilization by project and program. InterMune is a publicly traded biotech company focused on developing and commercializing innovative therapies in hepatology and pulmonology.

Titan Pharmaceuticals chooses R&D Logic suite for Planning and Tracking

Titan Pharmaceuticals Inc. located in South San Francisco, California, has selected the full R&D Logic suite of software to support corporate planning, tracking, time collection and corporate reporting and analysis. Titan is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders.

Valentis selects R&D Time solution for tracking actual project effort

Valentis, Inc. located in Burlingame, California, has selected R&D Time to replace in-house time and attendance system and complete the R&D Logic enterprise suite that has been in used for the past four years. Valentis is a biotechnology company engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market.

Avidia selects R&D Logic enterprise solution for planning and tracking

Avidia, Inc. located in Mountain View, California, has selected R&D Manage, R&D Time and R&D P&L to support corporate strategic and operational planning as well as monthly tracking and analysis. Avidia is focused on developing a new class of therapeutic proteins for treatments in areas including autoimmunity, inflammation and oncology.

NeuroMolecular selects R&D Logic solution for corporate planning and tracking

NeuroMolecular Pharmaceuticals, Inc. located in Emeryville, California has selected R&D Manage™ and P&L platform to support project portfolio and corporate planning and tracking business processes. NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders.

EPIX Pharmaceuticals selects R&D Time™ as the new company time & attendance solution

Epix, who currently uses R&D Manage for their corporate budgeting and tracking, has decided to expand their usage of R&D Logic products and include R&D Time, a software tool specifically developed to collect project efforts by employee. R&D Time will replace the current time collection system.

Avigen selects R&D Logic solution to plan and track corporate financials and resources

Avigen, Inc. located in Alameda, California has selected R&D Manage and R&D Time software to support corporate and project planning and tracking activities. Avigen (NASDAQ: AVGN) is a leader in the development of gene therapy products to treat serious, chronic diseases.

EPIX Medical selects R&D Manage™ solution to plan and track corporate financials and resources by project

EPIX Medical, Inc. located in Cambridge, Massachusetts has selected R&D Logic software solution and services for managing their corporate and project financials. EPIX Medical (NASDAQ: EPIX)is a specialty pharmaceutical company and a worldwide leader in the discovery and development of targeted MRI contrast agents for the diagnosis and clinical management of disease.

R&D Logic's Customers Meet Over the Web

In an effort to better serve our customers, R&D Logic organizes quarterly webinars to discuss topics of common interest. The first such webinars are beeing held this month to present new features of the latest product release. Watch for anouncements of future topics!

BioMedicines selects R&D Manage™ solution to budget, forecast and track their financials and project resources

BioMedicines, Inc. located in Emeryville, California has selected R&D Logic software solution and services for managing their corporate and project financials. BioMedicines specializes in developing and systematically generating new uses for clinical-stag drugs purchased or licensed from major pharmaceutical companies.

NPS Pharmaceuticals has selected the R&D Manage™ solution to support budgeting, forecasting and tracking of their world wide expenses

NPS Pharmaceuticals, Inc. located in Salt Lake City, Utah has subscribed to R&D Logic software solution and services. NPS Pharmaceuticals was founded in 1986 and is engaged in the discovery and development of novel, small molecule drugs and recombinant peptides that address a variety of important diseases. With operations in both US and Canada, NPSP will start using the R&D Manage software by developing a detailed global budget across the various organizations.

Discovery Partners International has selected the R&D Manage™ solution to plan and manage their consolidated financials

Discovery Partners International, Inc. located in San Diego, California has subscribed to R&D Logic software solution and services. Discovery Partners has become a leader in drug discovery collaborations by offering integrated services and products that span the drug discovery continuum including target characterization, high throughput screening, lead generation, lead optimization, high throughput synthesis automation, and gene expression analysis. With operations in both US and Europe, DPI will start using the R&D Manage software by developing a detailed global budget for the entire corporation.

Novacea has opted for the R&D Manage™ solution to plan and manage their financials

Novacea, Inc. located in South San Francisco, California has subscribed to R&D Logic software solution and services. Novacea is a rapidly growing drug development company that has the exclusive worldwide rights to the Oregon Health & Science University (OHSU) technology for dose and a method of use of calcitriol and its analogs, potentially providing a major breakthrough in the treatment of cancer. R&D Manage will be first used to create a long range plan of the Company financials, with an emphasis on clinical trial costs.

Guilford Pharamceuticals has selected R&D Manage™ solution to support their objective driven financial planning and tracking process

Guilford Pharmaceuticals, Inc. located in Baltimore, Maryland has subscribed to R&D Logic software solution and services. With implementation efforts already under way, we are looking forward to integrating the R&D Manage software within a unified platform for budgeting, forecasting and tracking of the Guilford financials.

CellGate has selected R&D Manage™ to support budgeting, forecasting and monthly reporting activities for their rapidly expanding operations.

CellGate, Inc. located in Sunnyvale, California has subscribed to R&D Logic software solution and services. CellGate is a pioneer in the application and development of transporter molecules to deliver novel medicines into cells and through tissues.

Neurogen (Connecticut) and Pharmos (New Jersey) have selected R&D Manage to support their budgeting, forecasting and monthly reporting activities.

NEUROGEN Corporation has acquired a global license for using R&D Manage software and services. Neurogen is a leader in both the discovery and development of new drug candidates and in the development and integration of new drug discovery technologies, most notably its AIDD (Accelerated Intelligent Drug Discovery) system.

PHARMOS Corporation has subscribed to R&D Manage software and services. Additionally, R&D Manage will support consolidation between the Israel and US divisions. Pharmos Corporation is a bio-pharmaceutical company focused on the discovery, development and commercialization of therapeutics for the central and peripheral nervous systems, and ophthalmologic, cardiovascular and inflammation-related indications.

Neurogenetics acquires global license for using R&D Manage.

NEUROGENETICS, Inc. has subscribed to R&D Manage software and services. Neurogenetics is a San Diego-based emerging biopharmaceutical company focused on the development of therapeutics for Alzheimer’s disease (AD) and related neurodegenerative disorders, including Parkinson’s disease (PD), Huntington’s disease (HD), stroke, amyotrophic lateral sclerosis (ALS), epilepsy and chronic pain.

HYSEQ and ZYOMYX have selected R&D Manage™ to budget, forecast, track and manage their R&D operating expenses.

Hyseq, Inc. and Zyomyx have recently subscribed to R&D Manage software and services. Hyseq, located in Sunnyvale, California, applies its genomics platform to find and develop biopharmaceuticals products. Zyomyx, located in Hayward, California, is developing a new generation of biochips which will enable miniaturized, ultrahigh-throughput protein analyses to bridge the technology gap in the discovery process for the biological and life sciences industry.

10 biotech and pharmaceutical companies are now using our solution for budgeting, forecasting and tracking.

NeoTherapeutics, Inc. and Metabolex, Inc. have recently joined our user community. NeoTherapeutics, located in Irvine, California, is a development-stage biopharmaceutical company engaged in the discovery and advancement of novel therapeutic agents intended to treat neurological and psychiatric diseases and conditions. Metabolex discovers and develops new drugs for type 2 diabetes and brings to market novel drugs with distinct and complementary modes of action, to address the full range of defects underlying diabetes. Both companies will be using R&D Manage on a subscription mode and will first use the system to create their 2002 budgets.

Valentis, Inc. has subscribed to R&D Manage.

Valentis, Inc, is taking the discoveries of genomics research and applying proprietary delivery systems to create therapeutics with improved safety, efficacy or dosing convenience. Valentis has what is believed to be the broadest array of technologies and intellectual property for the delivery of biopharmaceuticals in the industry. R&D Manage will be integrated with Platinum and the local time reporting system. The company has centers in three locations: The Woodlands, Texas, which houses the team focused on preclinical Research & Development; London, England, where PolyMASC operates as a wholly-owned subsidiary and focuses on polymer-based delivery; and Burlingame, California,which is the company headquarters as well as the center for manufacturing and clinical development. R&D Manage will be rolled out to the US locations in April 2001.

Intrabiotics has subscribed to R&D Manage.

Intrabiotics Pharmaceuticals Inc, is a biopharmaceutical company developing novel antibacterial and antifungal drugs for the prevention or treatment of serious infectious diseases, including those related to the phenomenon of multi-drug resistant microbes and the infectious complications of neutropenia. R&D Manage™ will be integrated with MAS90 and local time reporting system.

Two new companies have joined our R&D Manage subscription community in the month of December, 2000.

Sunesis Pharmaceuticals is applying a revolutionary new approach to drug discovery that is based on a novel chemical methodology combined with critical insights into the nature of molecular recognition between natural macromolecules and their substrates or ligands. Sunesis will be using R&D Manage™ and the electronic integration with Quick Books.
Cytokinetics Inc. is focused on the complementary missions of drug discovery and the commercialization of novel cellular bioinformatics technologies. We are excited to integrate R&D Manage™ with the General Ledger of Great Plains accounting system.

BioSpace.com has subscribed to R&D Manage

BioSpace.com, Inc. is the most heavily trafficked business-to-business life sciences site on the Internet today. The company has selected R&D Manage as the tool to budget, forecast and track their P&L by project and by organization. Due to the accelerated implementation process that has already been kicked-off, BioSpace will be productional in less then 5 weeks and build their 2001 Budget in R&D Manage.

GeneSoft chooses R&D Manage over Hyperion

GeneSoft, Inc. a South San Francisco company focused on pharmaceuticals that modulate gene expression, has subscribed to R&D Manage with Quick Books for budgeting and tracking of R&D expenses.

Collabra Pharma leases R&D Manage

Collabra Pharma, Inc., a drug development company based in South San Francisco, has chosen R&D Manage™ with Quick Books to manage their budgeting and tracking of R&D expenses.